Browse studies

Find your next paid study

27,306 recruiting studies available now

Phase I Clinical Trial of Locoregionally (LR) Delivered Autologous B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Adults With Recurrent Glioblastoma Multiforme (GBM)

This is an open label, non-randomized, single site Phase I study to test the manufacturing feasibility and safety of locoregional (LR) administration of B7-H3C…

Brain and Nervous System

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Stanford UniversityNCT05474378

Phase 3

A Phase III, Randomized, Double-Blind Placebo-Controlled, Non-Inferiority, Multi-Center Study of the Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

Hydroxychloroquine (HCQ) is a systemic lupus erythematosus (SLE) medication that has been very effective in reducing lupus disease activity and keeping patient…

Systemic Lupus Erythematosus

Estimated

~$50 – $2,250

Actual pay is set by the research site.

NYU Langone HealthNCT05799378

Phase 2

A Phase 2, Randomized, Controlled, Multicenter Study of Vosoritide in Children With Idiopathic Short Stature

The purpose of this study is to evaluate i) the effect of multiple doses of vosoritide and ii) the effect of the therapeutic dose of vosoritide compared to hum…

Idiopathic Short Stature

Estimated

~$75 – $2,800

Actual pay is set by the research site.

BioMarin PharmaceuticalNCT06382155

The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures: An International Multicenter Prospective Study

This is an international multicenter prospective observational study. Patients with radiologically confirmed, symptomatic, single- or multilevel contiguous TL …

Osteoporotic FracturesOsteoporosis

Estimated

~$10 – $750

Actual pay is set by the research site.

AO Foundation, AO SpineNCT07027306

Phase 2

Ropeginterferon Alfa-2b for MDS/MPN Overlap Syndromes, Including CMML and MDS/MPN-RS-T

This phase II trial tests the safety, best dose, and effectiveness of ropeginterferon alfa-2b for the treatment of patients with myelodysplastic syndrome/myelo…

Atypical Chronic Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic/Myeloproliferative Neoplasm+2 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Jonsson Comprehensive Cancer CenterNCT07468916

International Pediatric Adrenocortical Tumor Registry

This study aims to collect demographic and medical information including detailed family history of cancer of children and adolescents with adrenocortical tumo…

Adrenocortical Tumor

Estimated

~$10 – $750

Actual pay is set by the research site.

St. Jude Children's Research HospitalNCT00700414

Observational

Exercise Effects on Adipose Tissue Structure and Function

Participants will be randomized into one of two different experimental groups: 1) Exercise group and 2) No exercise (control group). Subject participation in t…

ObesityMetabolic SyndromeMetabolic Disease+3 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MichiganNCT04812314

Role of Gut Microbiome in Cancer Therapy

This study examines how gut microbiome can affect cancer therapy in cancer patients undergoing cancer therapy or stem cell transplant. The human microbiome aff…

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT05112614

Phase 1

A Phase I, Open-Label, Dose-Finding Study of TVB-2640 Administered in Combination With Enzalutamide (Xtandi) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

The purpose of this study is to determine what effects (good and bad) Enzalutamide and TVB-2640 have in the treatment of prostate cancer whose prostate cancer …

Prostatic Neoplasms, Castration-Resistant

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Weill Medical College of Cornell UniversityNCT05743621

Observational

mHealth to Improve Medication Adherence Among Latina Breast Cancer Patients Experiencing Non-Medical Drivers of Health

Background: Hormonal therapy (HT) is highly effective for nearly all breast cancer patients with hormone receptor-positive tumors, which are about 80% of all b…

Treatment Adherence

Estimated

~$10 – $750

Actual pay is set by the research site.

The University of Texas Health Science Center at San AntonioNCT07706127

Phase 1

An Open Label, Multicenter Study of DPTX3186 to Evaluate Safety, Tolerability, and Pharmacokinetics in Subjects With Known Wnt Pathway Activated Solid Tumors Where No Other Treatments Exist

This is a first-in human clinical study of DPTX3186 in subjects with Wnt-pathway activated solid tumors where no other treatments exist. The study will evaluat…

Solid Tumors

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Dewpoint TherapeuticsNCT07312903

Phase 2

Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia

Changing the schedule of intrathecal chemotherapy to be given before and during blinatumomab will maintain the anti-leukemic effects of this drug while at the …

Acute Lymphoblastic Leukemia

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Northside Hospital, Inc.NCT05519579